Susquehanna International Group
ORKA

Susquehanna International Group’s Oruka Therapeutics ORKA Stock Holding History

Susquehanna International Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
29,400
+12,200
+71% +$424K ﹤0.01% 6990
2025
Q4 		$521K Buy
17,200
+4,300
+33% +$120K ﹤0.01% 8693
2025
Q3 		$248K Buy
+12,900
New +$191K ﹤0.01% 10537
2024
Q4 		– Sell
-12,500
Closed -$306K – 13453
2024
Q3 		$306K Buy
12,500
+10,875
+669% +$378K ﹤0.01% 9555
2024
Q2 		$74.7K Buy
+1,625
New +$64.8K ﹤0.01% 11208
2024
Q1 		– Sell
-1,300
Closed -$26.5K – 13569
2023
Q4 		$26.5K Sell
1,300
-1,083
-45% -$24.3K ﹤0.01% 11914
2023
Q3 		$57.5K Sell
2,383
-1,034
-30% -$25.3K ﹤0.01% 11232
2023
Q2 		$83.2K Sell
3,417
-800
-19% -$19.7K ﹤0.01% 11080
2023
Q1 		$101K Buy
4,217
+417
+11% +$11K ﹤0.01% 11292
2022
Q4 		$108K Sell
3,800
-3,358
-47% -$86.1K ﹤0.01% 10902
2022
Q3 		$177K Sell
7,158
-2,942
-29% -$83.1K ﹤0.01% 11016
2022
Q2 		$302K Buy
10,100
+5,225
+107% +$148K ﹤0.01% 9551
2022
Q1 		$135K Buy
4,875
+758
+18% +$18.8K ﹤0.01% 11659
2021
Q4 		$106K Buy
+4,117
New +$124K ﹤0.01% 12109
2021
Q2 		– Sell
-1,100
Closed -$48K – 13391
2021
Q1 		$48K Buy
+1,100
New +$57.7K ﹤0.01% 12042

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Susquehanna International Group's ORKA Position: Q1 2026 in Review

Susquehanna International Group increased its Oruka Therapeutics (ORKA) stake by 142% in Q1 2026, buying an estimated $428K and bringing the position to 20,984 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #7816.

Susquehanna International Group first reported a position in ORKA in Q2 2015 and has held it in 15 quarters since. The position peaked at $3.59M in Q1 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Susquehanna International Group held 20,984 shares of Oruka Therapeutics worth $1.03M as of Q1 2026.
  • Susquehanna International Group bought 12,319 Oruka Therapeutics shares in Q1 2026, an estimated $428K.
  • Oruka Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7816 holding.
  • Susquehanna International Group first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 15 quarters since.
  • Susquehanna International Group's Oruka Therapeutics position peaked at $3.59M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.